Lastly, the HMOs 2'FL and 6'-sialyllactose (6'-SL) decreased intestinal injury in mouse and piglet models of NEC, which was associated with reductions in TLR4 activation (44). Here, TLR4 is linked to necrotizing enterocolitis.